Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno‐occlusive disease [PDF]
Respirology Case Reports, 2023 We present a 41‐year‐old man with idiopathic interstitial pneumonia and pulmonary hypertension (PH) in the setting of a non‐autoimmune background whose clinical presentation masqueraded pulmonary veno‐occlusive disease (PVOD).
Hiroki Nakayama +13 more
doaj +2 more sources
Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
Clinical Medicine Insights: Oncology, 2015 Introduction Gemcitabine is a chemotherapeutic agent frequently used by for the treatment of several malignancies both in the adjuvant and metastatic setting.
Célia Turco +10 more
doaj +3 more sources
Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension
Journal of Investigative Medicine High Impact Case Reports, 2019 Pulmonary veno-occlusive disease (PVOD) is a rare entity that is usually mistaken with pulmonary arterial hypertension (PAH) but is considered class I′ of PAH. It is important to subclassify PVOD and distinguish it from PAH as treatment with vasodilators
Said Hajouli MD +2 more
doaj +2 more sources
DIAGNOSTIC SPECIFICS OF PULMONARY VENO-OCCLUSIVE DISEASE
Российский кардиологический журнал, 2012 The authors present the two-year follow-up of a female patient with severe pulmonary hypertension and a rare pathology – pulmonary veno-occlusive disease. Due to the treatment with low-dose prednisolone, in combination with warfarin, coraxan, and oxygen,
E. A. Zhuk +4 more
doaj +1 more source
Clinical features of canine pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis
Journal of Veterinary Internal Medicine, 2019 Background Histologic features of pulmonary veno‐occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) have been described in dogs but without a thorough clinical description.
Carol R. Reinero +5 more
doaj +2 more sources
Reactive Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-Occlusive Disease in a Patient with Repaired Scimitar Syndrome [PDF]
Case Reports in Cardiology, 2016 Pulmonary capillary hemangiomatosis (PCH) is a rare histological substrate within the spectrum of pulmonary arterial hypertension that possibly represents an unusual manifestation of pulmonary veno-occlusive disease (PVOD).
Eva Güttinger +6 more
doaj +2 more sources
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension [PDF]
European Respiratory Review, 2009 A 27-yr-old female with a 6-month diagnosis of idiopathic pulmonary arterial hypertension (PAH) confirmed elsewhere was referred to our centre with worsening dyspnoea.
M. Palazzini, A. Manes
doaj +2 more sources
BMC Pulmonary Medicine, 2018 Background Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare cause of pulmonary hypertension that is associated with malignancies and is marked by the presence of non-occlusive tumor emboli and fibrocellular intimal proliferation of small ...
Dante A. Suffredini +6 more
doaj +2 more sources
Targeted therapy in pulmonary veno-occlusive disease: time for a rethink? [PDF]
BMC Pulmonary Medicine, 2019 Background Pulmonary veno-occlusive disease (PVOD) is a rare condition with poor prognosis, and lung transplantation is recommended as the only curative therapy.
Qin Luo +8 more
doaj +2 more sources
Pulmonary hypertension secondary to veno-occlusive disease in a 15-years old boy: a case report.
Critical Care Innovations, 2022 Pulmonary hypertension (PH) is a pathology characterized by a mean arterial pressure of the pulmonary artery greater than 20 mmHg and with a classification system based on its etiologies.
Pedro Pinheiro Barros +4 more
doaj +1 more source